🇺🇸 FDA
Patent

US 7311916

Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

granted A61KA61K2039/505A61K39/00

Quick answer

US patent 7311916 (Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K39/00, A61K47/62, A61P